Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

SHE:300255 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 4, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	44,694	18,372	11,957	5,036	7,472	5,693
Market Cap Growth	178.04%	53.65%	137.41%	-32.59%	31.26%	11.92%
Enterprise Value	46,995	20,352	14,091	6,817	8,617	6,631
Last Close Price	48.63	19.99	13.01	5.47	8.09	6.15
PE Ratio	-	-	-	287.58	31.99	22.52
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	48.16	17.82	8.48	2.16	2.52	2.41
PB Ratio	30.23	11.96	6.64	1.65	2.43	2.00
P/TBV Ratio	36.85	14.65	8.02	1.80	2.68	2.20
P/OCF Ratio	926.83	326.80	354.53	1611.41	2602.11	-
EV/Sales Ratio	50.64	19.74	9.99	2.92	2.90	2.81
EV/EBITDA Ratio	-	-	-	41.33	22.68	15.64
EV/EBIT Ratio	-	-	-	63.13	26.59	17.98
EV/FCF Ratio	-322.99	-	-	-	-	-
Debt / Equity Ratio	1.75	1.66	1.32	0.82	0.57	0.47
Debt / EBITDA Ratio	-	-	-	15.10	4.58	3.14
Asset Turnover	0.20	0.23	0.27	0.42	0.61	0.56
Inventory Turnover	0.62	0.62	0.85	0.56	0.60	0.45
Quick Ratio	0.24	0.25	0.29	0.72	0.52	0.67
Current Ratio	0.87	0.91	1.19	2.18	1.97	2.12
Return on Equity (ROE)	-18.04%	-15.83%	-51.43%	0.33%	7.81%	9.01%
Return on Assets (ROA)	-2.57%	-2.45%	-13.46%	1.20%	4.15%	5.41%
Return on Invested Capital (ROIC)	-5.08%	-4.60%	-26.38%	1.34%	7.22%	9.15%
Return on Capital Employed (ROCE)	-8.50%	-7.70%	-42.80%	2.50%	9.40%	11.70%
Earnings Yield	-0.67%	-1.36%	-10.37%	0.35%	3.13%	4.44%
FCF Yield	-0.33%	-1.00%	-1.72%	-8.50%	-4.08%	-6.73%
Dividend Yield	-	-	-	0.09%	0.32%	-
Payout Ratio	-	-	-	708.02%	26.50%	27.08%
Buyback Yield / Dilution	-35.95%	-0.58%	-4.91%	6.27%	0.23%	0.24%
Total Shareholder Return	-35.95%	-0.58%	-4.91%	6.37%	0.55%	0.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.